Model variables of interest . | Coefficient . | SE . | 95% confidence interval . | P value . |
---|---|---|---|---|
Sex (female) | ||||
Male | −2.056335 | 0.6174192 | −3.266454 to 0.8462152 | <0.001a |
Nuclear genome composition (S1 × S2) | ||||
N1 × N2 | −0.641442 | 1.010389 | −2.621767 to 1.338883 | 0.526 |
N1 × S2 | −0.4193836 | 0.9344747 | −2.25092 to 1.412153 | 0.654 |
N2 × S2 | −0.0495768 | 0.78571 | −1.58954 to 1.490386 | 0.950 |
Collection cohort (2019) 2021 | 1.080008 | 0.7596106 | −0.4088018 to2.568817 | 0.155 |
Time in the lab (continuous) | 0.0022869 | 0.0021999 | −0.0020248 to 0.0065987 | 0.299 |
Mitochondrial haplotype (S1) | ||||
N1 | −0.9979337 | 0.9280818 | −2.816941 to 0.8210731 | 0.282 |
N2 | −0.7464586 | 0.9039951 | −2.518257 to 1.025339 | 0.409 |
S2 | 0.0527731 | 0.7555242 | −1.428027 to 1.533573 | 0.944 |
Interactions (female × S1) | ||||
Male × N1 | 1.380488 | 1.02512 | −0.6287107 to 3.389688 | 0.178 |
Male × N2 | 1.343283 | 0.8051091 | −0.2347022 to 2.921267 | 0.095b |
Male × S2 | 2.674684 | 0.7840828 | 1.137909 to 4.211458 | 0.001a |
Arena (1) | ||||
2 | 0.55875`73 | 0.6469022 | −0.7091478 to 1.826662 | 0.388 |
3 | −0.4334884 | 0.5443319 | −1.500359 to 0.6333825 | 0.426 |
4 | −0.3742522 | 0.4224166 | −1.202173 to 0.453669 | 0.376 |
5 | −0.3751059 | 0.5718214 | −1.495855 to 0.7456435 | 0.512 |
6 | 0.0463329 | 0.4478695 | −0.8314751 to 0.924141 | 0.918 |
7 | −0.2422762 | 0.5147744 | −1.251216 to 0.7666631 | 0.638 |
8 | 0.1908012 | 0.5382889 | −0.8642256 to 1.245828 | 0.723 |
Model variables of interest . | Coefficient . | SE . | 95% confidence interval . | P value . |
---|---|---|---|---|
Sex (female) | ||||
Male | −2.056335 | 0.6174192 | −3.266454 to 0.8462152 | <0.001a |
Nuclear genome composition (S1 × S2) | ||||
N1 × N2 | −0.641442 | 1.010389 | −2.621767 to 1.338883 | 0.526 |
N1 × S2 | −0.4193836 | 0.9344747 | −2.25092 to 1.412153 | 0.654 |
N2 × S2 | −0.0495768 | 0.78571 | −1.58954 to 1.490386 | 0.950 |
Collection cohort (2019) 2021 | 1.080008 | 0.7596106 | −0.4088018 to2.568817 | 0.155 |
Time in the lab (continuous) | 0.0022869 | 0.0021999 | −0.0020248 to 0.0065987 | 0.299 |
Mitochondrial haplotype (S1) | ||||
N1 | −0.9979337 | 0.9280818 | −2.816941 to 0.8210731 | 0.282 |
N2 | −0.7464586 | 0.9039951 | −2.518257 to 1.025339 | 0.409 |
S2 | 0.0527731 | 0.7555242 | −1.428027 to 1.533573 | 0.944 |
Interactions (female × S1) | ||||
Male × N1 | 1.380488 | 1.02512 | −0.6287107 to 3.389688 | 0.178 |
Male × N2 | 1.343283 | 0.8051091 | −0.2347022 to 2.921267 | 0.095b |
Male × S2 | 2.674684 | 0.7840828 | 1.137909 to 4.211458 | 0.001a |
Arena (1) | ||||
2 | 0.55875`73 | 0.6469022 | −0.7091478 to 1.826662 | 0.388 |
3 | −0.4334884 | 0.5443319 | −1.500359 to 0.6333825 | 0.426 |
4 | −0.3742522 | 0.4224166 | −1.202173 to 0.453669 | 0.376 |
5 | −0.3751059 | 0.5718214 | −1.495855 to 0.7456435 | 0.512 |
6 | 0.0463329 | 0.4478695 | −0.8314751 to 0.924141 | 0.918 |
7 | −0.2422762 | 0.5147744 | −1.251216 to 0.7666631 | 0.638 |
8 | 0.1908012 | 0.5382889 | −0.8642256 to 1.245828 | 0.723 |
The coefficient is presented relative to the baseline for each predictor variable of interest. The baseline for each predictor is written in parentheses after the predictor label. The responding variable is the proportion of survival for each level of the variable of interest. The four populations included are Northern 1 (N1), Northern 2 (N2), Southern 1 (S1), and Southern 2 (S2).
aSignificant results.
bMarginally significant interactions.
Model variables of interest . | Coefficient . | SE . | 95% confidence interval . | P value . |
---|---|---|---|---|
Sex (female) | ||||
Male | −2.056335 | 0.6174192 | −3.266454 to 0.8462152 | <0.001a |
Nuclear genome composition (S1 × S2) | ||||
N1 × N2 | −0.641442 | 1.010389 | −2.621767 to 1.338883 | 0.526 |
N1 × S2 | −0.4193836 | 0.9344747 | −2.25092 to 1.412153 | 0.654 |
N2 × S2 | −0.0495768 | 0.78571 | −1.58954 to 1.490386 | 0.950 |
Collection cohort (2019) 2021 | 1.080008 | 0.7596106 | −0.4088018 to2.568817 | 0.155 |
Time in the lab (continuous) | 0.0022869 | 0.0021999 | −0.0020248 to 0.0065987 | 0.299 |
Mitochondrial haplotype (S1) | ||||
N1 | −0.9979337 | 0.9280818 | −2.816941 to 0.8210731 | 0.282 |
N2 | −0.7464586 | 0.9039951 | −2.518257 to 1.025339 | 0.409 |
S2 | 0.0527731 | 0.7555242 | −1.428027 to 1.533573 | 0.944 |
Interactions (female × S1) | ||||
Male × N1 | 1.380488 | 1.02512 | −0.6287107 to 3.389688 | 0.178 |
Male × N2 | 1.343283 | 0.8051091 | −0.2347022 to 2.921267 | 0.095b |
Male × S2 | 2.674684 | 0.7840828 | 1.137909 to 4.211458 | 0.001a |
Arena (1) | ||||
2 | 0.55875`73 | 0.6469022 | −0.7091478 to 1.826662 | 0.388 |
3 | −0.4334884 | 0.5443319 | −1.500359 to 0.6333825 | 0.426 |
4 | −0.3742522 | 0.4224166 | −1.202173 to 0.453669 | 0.376 |
5 | −0.3751059 | 0.5718214 | −1.495855 to 0.7456435 | 0.512 |
6 | 0.0463329 | 0.4478695 | −0.8314751 to 0.924141 | 0.918 |
7 | −0.2422762 | 0.5147744 | −1.251216 to 0.7666631 | 0.638 |
8 | 0.1908012 | 0.5382889 | −0.8642256 to 1.245828 | 0.723 |
Model variables of interest . | Coefficient . | SE . | 95% confidence interval . | P value . |
---|---|---|---|---|
Sex (female) | ||||
Male | −2.056335 | 0.6174192 | −3.266454 to 0.8462152 | <0.001a |
Nuclear genome composition (S1 × S2) | ||||
N1 × N2 | −0.641442 | 1.010389 | −2.621767 to 1.338883 | 0.526 |
N1 × S2 | −0.4193836 | 0.9344747 | −2.25092 to 1.412153 | 0.654 |
N2 × S2 | −0.0495768 | 0.78571 | −1.58954 to 1.490386 | 0.950 |
Collection cohort (2019) 2021 | 1.080008 | 0.7596106 | −0.4088018 to2.568817 | 0.155 |
Time in the lab (continuous) | 0.0022869 | 0.0021999 | −0.0020248 to 0.0065987 | 0.299 |
Mitochondrial haplotype (S1) | ||||
N1 | −0.9979337 | 0.9280818 | −2.816941 to 0.8210731 | 0.282 |
N2 | −0.7464586 | 0.9039951 | −2.518257 to 1.025339 | 0.409 |
S2 | 0.0527731 | 0.7555242 | −1.428027 to 1.533573 | 0.944 |
Interactions (female × S1) | ||||
Male × N1 | 1.380488 | 1.02512 | −0.6287107 to 3.389688 | 0.178 |
Male × N2 | 1.343283 | 0.8051091 | −0.2347022 to 2.921267 | 0.095b |
Male × S2 | 2.674684 | 0.7840828 | 1.137909 to 4.211458 | 0.001a |
Arena (1) | ||||
2 | 0.55875`73 | 0.6469022 | −0.7091478 to 1.826662 | 0.388 |
3 | −0.4334884 | 0.5443319 | −1.500359 to 0.6333825 | 0.426 |
4 | −0.3742522 | 0.4224166 | −1.202173 to 0.453669 | 0.376 |
5 | −0.3751059 | 0.5718214 | −1.495855 to 0.7456435 | 0.512 |
6 | 0.0463329 | 0.4478695 | −0.8314751 to 0.924141 | 0.918 |
7 | −0.2422762 | 0.5147744 | −1.251216 to 0.7666631 | 0.638 |
8 | 0.1908012 | 0.5382889 | −0.8642256 to 1.245828 | 0.723 |
The coefficient is presented relative to the baseline for each predictor variable of interest. The baseline for each predictor is written in parentheses after the predictor label. The responding variable is the proportion of survival for each level of the variable of interest. The four populations included are Northern 1 (N1), Northern 2 (N2), Southern 1 (S1), and Southern 2 (S2).
aSignificant results.
bMarginally significant interactions.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.